We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Elevated Blood Sugar a Cardiovascular Disease Risk Not Linked to Cholesterol Levels

By LabMedica International staff writers
Posted on 22 Sep 2014
Individuals with prediabetes and diabetes are at high risk for cardiovascular events such as myocardial infarction that can be predicted by elevated levels of troponin T.

The protein troponin T binds to tropomyosin and helps position it on actin, and with the rest of the troponin complex modulates contraction of striated muscle. In patients with stable coronary artery disease, troponin T concentrations have been found to be significantly associated with the incidence of cardiovascular death and heart failure.

Image: Troponin T binds to tropomyosin and helps position it on actin, and with the rest of the troponin complex modulates contraction of striated muscle. In patients with stable coronary artery disease, troponin T concentrations have been found to be significantly associated with the incidence of cardiovascular death and heart failure (Photo courtesy of Wikimedia Commons).
Image: Troponin T binds to tropomyosin and helps position it on actin, and with the rest of the troponin complex modulates contraction of striated muscle. In patients with stable coronary artery disease, troponin T concentrations have been found to be significantly associated with the incidence of cardiovascular death and heart failure (Photo courtesy of Wikimedia Commons).

In a recent study, investigators at Johns Hopkins University (Baltimore, MD, USA) reported that individuals with pre-diabetes or diabetes who displayed elevated levels of troponin T were approximately six times more likely to experience a cardiovascular incident than were those with normal blood sugar levels.

These findings were obtained by using a highly sensitive troponin T assay to determine levels of the protein in blood samples from more than 9,000 participants in the Atherosclerosis Risk in Communities Study (ARIC) at two time points. At the first measurement those with diabetes were two and a half times more likely to have elevated troponin levels than those without. At follow-up 14 years later, diabetics with elevated troponin were seen to be six times more likely to develop heart failure and four times more likely to have a heart attack.

Due to the link between cardiovascular disease and diabetes, patients with newly diagnosed diabetes are typically prescribed a cholesterol-lowering statin. "However, this study suggests that there may be people with diabetes whose heart risk may have nothing to do with cholesterol," said first author Dr. Elizabeth Selvin, associate professor of epidemiology at Johns Hopkins University. "Statin treatment may not be sufficient to prevent damage to the heart in people with diabetes. Even though there may be no symptoms yet, our research suggests there is microvascular damage being done to the heart which is leading to heart failure and even death. It puts what we know about heart damage in diabetes on its head. It looks like diabetes may be slowly killing heart muscle in ways we had not thought of before."

The study was published in the August 2014 online edition of the journal Circulation.

Related Links:
Johns Hopkins University


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Human Insulin CLIA
Human Insulin CLIA Kit
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution

Latest Clinical Chem. News

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability